去纤维钠上市价格

(Defibrotide) is currently recognized as the most promising new drug for the treatment of hepatic veno-occlusive disease (HVOD) after hematopoietic stem cell transplantation (HSCT). It has anticoagulant, fibrinolytic, and anti-inflammatory effects. It was first approved for marketing in the EU in 2013, and in 2016 it was approved by the FDA and approved for marketing in the United States.

Defibrotide sodium is an adenosine receptor agonist with multiple effects. Defibrotide sodium can act on the adenosine A1/A2 receptors of endothelial cells to produce a variety of downstream effects. This receptor is involved in the regulation of endothelial cells and the response of endothelial cells to injury. Not only that, defibrotide sodium (defibrinoside) can also reduce the expression of cell adhesion molecules on the surface of endothelial cells, thereby reducing the adhesion of leukocytes to vascular endothelial cells and reducing the inflammatory damage of endothelial cells.

Defibrotide sodium (defibrotide) has played a positive role in multiple studies on the prevention and treatment of hepatic veno-occlusive disease after HSCT, effectively increasing the survival rate of patients, and is a safe and effective drug.

Defibrotide sodium has not been approved for sale in the United States for a long time. So what is its price after it is launched?

It is understood that the price of defibrotide sodium (defibrinoside) when marketed overseas is around RMB 22,000. As an orphan drug, defibrination sodium is also difficult to purchase. If it is inconvenient for patients to go abroad, domestic regular overseas medical consulting service companies will be a good choice. Medical Travel is a company specializing in transnational medical consulting. It has long-term cooperation with many foreign pharmacies and hospitals and can help patients buy genuine defibrinated sodium.

The above is the price introduction of (Defibroside). The price of overseas drugs will inevitably change due to the exchange rate and other factors. For details, please refer to the information provided by the Medical Companion Travel Service. If you have other questions, you can also consult our Medical Companion Travel Service.